These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2706326)

  • 21. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
    Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
    Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
    Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
    Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of early course of breast carcinoma by thymidine labeling.
    Meyer JS; Friedman E; McCrate MM; Bauer WC
    Cancer; 1983 May; 51(10):1879-86. PubMed ID: 6831353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
    Winstanley J; Cooke T; George WD; Murray G; Holt S; Croton R; Griffiths K; Nicholson R
    Br J Cancer; 1991 Jul; 64(1):99-101. PubMed ID: 1854633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report (author's transl)].
    Cheix F; Biron A; Bailly C; Mayer M; Pommatau E; Saez S
    Nouv Presse Med; 1980 Mar; 9(13):933-5. PubMed ID: 7360626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
    Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T
    Cancer; 1988 Nov; 62(10):2183-90. PubMed ID: 3179930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer.
    Andry G; Suciu S; Pratola D; Sylvester R; Leclercq G; da Costa PM; Legros N; Andry-t'Hooft M; Verhest A; Mattheiem W
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):319-29. PubMed ID: 2702986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of estrogen receptors on survival and recurrence in patients with breast cancer without lymph node metastases.
    Maki HS; Hoehn JL
    Arch Surg; 1989 Mar; 124(3):377-80. PubMed ID: 2919970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.
    Castagnetta L; Traina A; Carruba G; Fecarotta E; Palazzotto G; Leake R
    Br J Cancer; 1992 Jul; 66(1):167-70. PubMed ID: 1637667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
    Koenders PG; Beex LV; Kloppenborg PW; Smals AG; Benraad TJ
    Breast Cancer Res Treat; 1992; 21(3):173-80. PubMed ID: 1515652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
    Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
    Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
    Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
    J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of prognostic factors in operable breast cancer.
    Hawkins RA; Tesdale AL; Killen ME; Jack WJ; Chetty U; Dixon JM; Hulme MJ; Prescott RJ; McIntyre MA; Miller WR
    Br J Cancer; 1996 Nov; 74(9):1469-78. PubMed ID: 8912547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.